Ketoconazole in Cushing's Disease: Is It Worth a Try?

Cited by (285)

Items 101–200 of 285

1. Synergistic cortisol suppression by ketoconazole–osilodrostat combination therapy
   Vincent Amodru, Thierry Christian Brue, Frédéric Castinetti · 2021 · Endocrinology Diabetes and Metabolism Case Reports
2. A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug–Drug Interaction Perpetrators
   Fatima Zahra Marok, Jan‐Georg Wojtyniak, Laura Maria Fuhr, Dominik Selzer, Matthias Georg Schwab, Johanna Weiß, Walter E. Haefeli, Thorsten Lehr · 2023 · Pharmaceutics
3. Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing’s Syndrome Treatment
   Sara G Creemers, Richard Abraham Feelders, Frank H. de Jong, Gaston J H Franssen, Yolanda B. de Rijke, Peter M. van Koetsveld, Leo J. Hofland · 2021 · The Journal of Clinical Endocrinology & Metabolism
4. Advances in the Medical Treatment of Cushing Disease
   Nicholas A. Tritos, Beverly M. K. Biller · 2020 · Endocrinology and Metabolism Clinics of North America
5. Medical Therapy for Cushing’s Syndrome in the Twenty-first Century
   Tritos, Nicholas A., Biller, Beverly M.K. · 2018 · Endocrinology and Metabolism Clinics of North America
6. Clinical use of pasireotide for Cushing's disease in adults
   Marco Boscaro, Filippo Ceccato, Carla Maria Scaroni · 2015 · Therapeutics and Clinical Risk Management
7. Long-term low-dose ketoconazole treatment in bilateral macronodular adrenal hyperplasia
   Sophie Comte-Perret, Anne Zanchi, Fulgencio Gómez · 2014 · Endocrinology Diabetes and Metabolism Case Reports
8. Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea
   Kyu Yeon Hur, Jung Hee Kim, Byung-Joon Kim, Min‐Seon Kim, Eun Jig Lee, Sung-Woon Kim · 2015 · Endocrinology and Metabolism
9. Multiple salivary cortisol measurements are a useful tool to optimize metyrapone treatment in patients with Cushing's syndromes treatment: case presentations
   Yoshida, Kenichi, Fukuoka, Hidenori, Odake, Yukiko, Nakajima, Shinsuke, Tachibana, Mariko, Ito, Jun, Hosokawa, Yusei, Yamada, Tomoko, Miura, Hiroshi, Suematsu, Natsu et al. · 2018 · Frontiers in Endocrinology
10. Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess
    Katharina R. Beck, Alex Odermatt · 2021 · Molecular and Cellular Endocrinology
11. The Mount Sinai Clinical Pathway for the Diagnosis and Management of Hypercortisolism due to Ectopic ACTH Syndrome
    Eva L. Alba, Emily Japp, Gustavo Gabriel Fernandez-Ranvier, Ketan K. Badani, Eric J. Wilck, Munir V. Ghesani, Andrea Wolf, Edward M. Wolin, Virginia Corbett, David Steinmetz et al. · 2022 · Journal of the Endocrine Society
12. MANAGEMENT OF ENDOCRINE DISEASE: Can we cure Cushing’s disease? A personal view
    XAVIER Y. BERTAGNA · 2018 · European Journal of Endocrinology
13. What is the role of medical therapy in adrenal-dependent Cushing’s syndrome?
    Braun, Leah T., Reincke, Martin · 2020 · Best Practice & Research Clinical Endocrinology & Metabolism
14. Synergistic Activity of Ketoconazole and Miconazole with Prochloraz in Inducing Oxidative Stress, GSH Depletion, Mitochondrial Dysfunction, and Apoptosis in Mouse Sertoli TM4 Cells
    Sabrina Petricca, Giuseppe Celenza, Carla Luzi, Benedetta Cinque, Anna Rita Lizzi, Nicola Franceschini, Claudio Festuccia, Roberto Iorio · 2022 · International Journal of Molecular Sciences
15. Cushing’s syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia
    Łukasz Działach, Joanna Sobolewska, Wioleta Respondek, Agnieszka Wojciechowska-Luźniak, Przemysław Witek · 2022 · HORMONES
16. Factors Affecting Dexamethasone Suppression Test Results
    A. Berlińska, R. Świątkowska-Stodulska, Krzysztof Sworczak · 2019 · Experimental and clinical endocrinology & diabetes
17. Ketoconazole in Cushing’s syndrome: a profile of its use
    Matt Shirley · 2021 · Drugs & Therapy Perspectives
18. A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome
    Elena Valassi, Anna Aulinas, Camilla A M Glad, Gudmundur Johannsson, Óskar Ragnarsson, Susan M. Webb · 2017 · Clinical Endocrinology
19. Current and Emerging Medical Therapies in Pituitary Tumors
    Nicolas Sahakian, Frédéric Castinetti, Thierry Christian Brue, Thomas Cuny · 2022 · Journal of Clinical Medicine
20. Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort
    Camila Viecceli, Ana Carolina Viana Mattos, Maria Carolina Bittencourt Costa, Rafael Borba de Melo, Ticiana da Costa Rodrigues, Mauro Antônio Czepielewski · 2022 · Frontiers in Endocrinology
21. The Adrenal Cortex
    Paul M. Stewart, John D C Newell-Price · 2016 · Elsevier eBooks
22. Sexual Dimorphism in Cellular and Molecular Features in Human ACTH-Secreting Pituitary Adenomas
    Francesca Pecori Giraldi, Maria Francesca Cassarino, Antonella Sesta, Mariarosa Terreni, Giovanni Battista Lasio, Marco Losa · 2020 · Cancers
23. Cushing's disease
    Amandine Ferrière, Antoine Tabarin · 2021 · La Presse Médicale
24. Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives
    Thomas Cuny, Anne Barlier, Richard Abraham Feelders, G. Weryha, Leo J. Hofland, Diego Ferone, Federico Gatto · 2014 · Annales d Endocrinologie
25. Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?
    Marine Ollivier, Magalie Haissaguerre, Amandine Ferrière, Antoine Tabarin · 2018 · European Journal of Endocrinology
26. Low-dose etomidate for the management of severe hypercortisolaemia in different clinical scenarios: a case series and review of the literature
    Agnieszka Łebek-Szatańska, Karolina M. Nowak, Wojciech Zgliczyński, Elżbieta Baum, Agnieszka Żyłka, Lucyna Papierska · 2019 · Therapeutic Advances in Endocrinology and Metabolism
27. Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations
    Maria Fleseriu, Richard Joseph Auchus, Irina Bancos, Beverly M. K. Biller · 2025 · Journal of the Endocrine Society
28. Levoketoconazole: a novel treatment for endogenous Cushing's syndrome
    Maria Fleseriu, Richard Joseph Auchus, Rosario Pivonello, Roberto Salvatori, Sabina Zacharieva, Beverly M. K. Biller · 2021 · Expert Review of Endocrinology & Metabolism
29. Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
    Maria Fleseriu, Chioma Iweha, Luiz Roberto Salgado, Tânia Longo Mazzuco, Federico Campigotto, Ricardo Maamari, Padiporn Limumpornpetch · 2019 · Frontiers in Endocrinology
30. Medical Management of Cushing Disease
    Nicholas A. Tritos, Beverly M. K. Biller · 2019 · Neurosurgery Clinics of North America
31. Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia
    Ann J. Miller, Lauren K. Brooks, Silpa Poola-Kella, Rana Malek · 2018 · Case Reports in Endocrinology
32. Ketoconazole as an Adrenal Steroidogenesis Inhibitor: Effectiveness and Risks in the Treatment of Cushing's Disease
    John D C Newell-Price · 2014 · The Journal of Clinical Endocrinology & Metabolism
33. Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome
    Marta Araujo-Castro, Cristina Lamas, Elisabeth Nowak, John D C Newell-Price, Martín Reincke, Frédéric Castinetti · 2025 · Endocrine Reviews
34. Current approaches to the pharmacological management of Cushing's disease
    Mark E. Molitch · 2014 · Molecular and Cellular Endocrinology
35. Systemic therapy of Cushing’s syndrome
    Niels Eckstein, Bodo Haas, Moritz David Sebastian Hass, Vladlena Pfeifer · 2014 · Orphanet Journal of Rare Diseases
36. Regulation of the EGFR Pathway by HSP90 Is Involved in the Pathogenesis of Cushing’s Disease
    Yue Shen, Chenxing Ji, Xuemin Jian, Juan Zhou, Qilin Zhang, Nidan Qiao, Yichao Zhang, Xuefei Shou, Xiang Zhou, Zengyi Ma · 2021 · Frontiers in Endocrinology
37. Repeat stereotactic radiosurgery for Cushing’s disease: outcomes of an international, multicenter study
    Gautam U. Mehta, D. Ding, Amitabh Gupta, H. Kano, Nathaniel D. Sisterson, N. Martínez-Moreno, M. Kršek, Huai-Che Yang, Cheng-Chia Lee, R. Liščák et al. · 2018 · Journal of Neuro-Oncology
38. Emerging drugs for Cushing’s disease
    Daniela Guelho, Ashley Barry Grossman · 2015 · Expert Opinion on Emerging Drugs
39. USP8: a novel therapeutic target for Cushing’s disease
    Fangfang Jian, Yanan Cao, Liuguan Bian, Qingfang Sun · 2015 · Endocrine
40. Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis
    Megan McGrath, Celena Ma, Douglas E. Raines · 2017 · Journal of Pharmacology and Experimental Therapeutics
41. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly
    Marco Giorgio Baroni, Francesco Giorgino, VINCENZO PEZZINO, Carla Maria Scaroni, Angelo Avogaro · 2016 · Nutrition Metabolism and Cardiovascular Diseases
42. Current strategies for the treatment of severe Cushing’s syndrome
    Krystallenia Alexandraki, Ashley Barry Grossman · 2015 · Expert Review of Endocrinology & Metabolism
43. Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease
    Rosario Pivonello, Maria Fleseriu, John D C Newell-Price, Akira Shimatsu, Richard Abraham Feelders, Pınar Kadıoğlu, Antoine Tabarin, Thierry Christian Brue, Eliza Brevoort Geer, A. Piacentini et al. · 2024 · Journal of Endocrinological Investigation
44. Cardiometabolic complications after Cushing’s disease remission
    Irene Tizianel, Laura Lizzul, Alessandro Mondin, Giacomo Voltan, Pierluigi Mazzeo, Carla Maria Scaroni, Mattia Barbot, Filippo Ceccato · 2025 · Journal of Endocrinological Investigation
45. Medical combination therapies in Cushing’s disease
    Lúcio Vilar, Luciana Ansaneli Naves, Márcio Carlos Machado, Marcello D. Bronstein · 2015 · Pituitary
46. Medical treatment of Cushing’s disease with concurrent diabetes mellitus
    Anna Mehlich, Marek Bolanowski, Dawid Mehlich, Przemysław Witek · 2023 · Frontiers in Endocrinology
47. Ketoconazole as second-line treatment for Cushing’s disease after transsphenoidal surgery: systematic review and meta-analysis
    Camila Viecceli, Ana Carolina Viana Mattos, Vânia Naomi Hirakata, Sheila Piccoli Garcia, Ticiana da Costa Rodrigues, Mauro Antônio Czepielewski · 2023 · Frontiers in Endocrinology
48. A Case of Severe Psychosis Due to Cushing's Syndrome Secondary to Primary Bilateral Macronodular Adrenal Hyperplasia
    Kajal Shah, Inderjit Mann, Kalpana Reddy, Geevarghese John · 2019 · Cureus
49. No Untoward Effect of Long‐Term Ketoconazole Administration on Electrocardiographic QT Interval in Patients with Cushing's Disease
    Martina De Martin, Paola Maria Toja, Karine Goulene, Piero Radaelli, Francesco Cavagnini, Marco Stramba‐Badiale, Francesca Pecori Giraldi · 2015 · Basic & Clinical Pharmacology & Toxicology
50. Osilodrostat for the treatment of Cushing’s disease
    Syeda Rasool, Brian W. Skinner · 2021 · Expert Opinion on Pharmacotherapy
51. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
    Daniela Regazzo, Alessandro Mondin, Carla Maria Scaroni, Gianluca Occhi, Mattia Barbot · 2022 · International Journal of Molecular Sciences
52. Management of Diabetes Mellitus in Acromegaly and Cushing’s Disease with Focus on Pasireotide Therapy: A Narrative Review
    Michelantonio De Fano, Alberto Falorni, Massimo Malara, Francesca Porcellati, Carmine Giuseppe Fanelli · 2024 · Diabetes Metabolic Syndrome and Obesity
53. Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome
    Arturo Vega‐Beyhart, Javier Laguna, Daniela Díaz-Catalán, Laura Boswell, Mireia Mora, Irene Halperín, Gregori Casals, Felicia Alexandra Hanzu · 2022 · Frontiers in Endocrinology
54. How best to monitor the specific side effects of medical treatments of Cushing’s disease
    Frédéric Castinetti · 2022 · Best Practice & Research Clinical Endocrinology & Metabolism
55. Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone
    Kevin C.J. Yuen, Andreas G. Moraitis, Dat Nguyen · 2017 · Journal of the Endocrine Society
56. Surgical Outcomes and Comorbidities in Cushing Disease: 30 Years of Experience in a Referral Center
    Antonio Jesús Martínez-Ortega, Eva Maria Venegas-Moreno, Elena Dios, Pablo Remón-Ruiz, Javier Márquez-Rivas, Eugenio Cárdenas Ruiz‐Valdepeñas, Ariel Matias Kaen, David A. Cano, Alfonso Soto‐Moreno · 2018 · World Neurosurgery
57. Fluconazole in the treatment of Cushing's disease
    Kharis A. Burns, Darshika Christie‐David, Jenny Elizabeth Gunton · 2016 · Endocrinology Diabetes and Metabolism Case Reports
58. Cushing’s Disease: Long-Term Effectiveness and Safety of Osilodrostat in a Polish Group of Patients with Persistent Hypercortisolemia in the Experience of a Single Center
    Łukasz Działach, Joanna Sobolewska, Wioleta Respondek, Katarzyna Szamotulska, Przemysław Witek · 2023 · Biomedicines
59. Medical treatment of functional pituitary adenomas, trials and tribulations
    Cristina Ana-Maria Capatina, Felicia Alexandra Hanzu, José Miguel Hinojosa‐Amaya, Maria Fleseriu · 2024 · Journal of Neuro-Oncology
60. Therapeutic strategies for Cushing’s syndrome: an update
    Filippo Ceccato, Mattia Barbot, Marialuisa Zilio, Nora Maria Elvira Albiger, Franco Mantero, Carla Maria Scaroni · 2014 · Expert Opinion on Orphan Drugs
61. Unmet needs on the current medical management of Cushing’s syndrome: results from a Delphi panel of Italian endocrinologists
    Rosario Pivonello, Carla Maria Scaroni, B. Polistena, Antonio Migliore, A. Giustina · 2023 · Journal of Endocrinological Investigation
62. New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A
    Mariana Fuertes, Julieta Tkatch, Josefina Rosmino, Leandro Nieto, Mirtha Adriana Guitelman, EDUARDO S. ARZT · 2018 · Frontiers in Endocrinology
63. Update on Medical Treatment of Cushing’s Syndrome
    Brendan R. Dillon, Nidhi Agrawal, Yair Schwarz, Kristen Dancel-Manning, Antoine Tabarin, André Lacroix, Leo J. Hofland, Richard Abraham Feelders · 2025 · Drugs
64. CYP24A1: structure, function, and physiological role
    René St‐Arnaud, Glenville Jones · 2023 · Elsevier eBooks
65. A review of Cushing's disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
    Márcio Carlos Machado, Maria Candida Barisson Villares Fragoso, Ayrton Custódio Moreira, César Luiz Boguszewski, Leonardo Vieira, Luciana Ansaneli Naves, Lúcio Vilar, Luiz Antônio de Araújo, Nina Rosa de Castro Musolino, Paulo Augusto Carvalho Miranda et al. · 2018 · Archives of Endocrinology and Metabolism
66. Fluconazole as a Safe and Effective Alternative to Ketoconazole in Controlling Hypercortisolism of Recurrent Cushing’s Disease: A Case Report
    Shu Teng Chai, Amalina Haydar Ali Tajuddin, Norasyikin A Wahab, Norlaila Mustafa, Norlela Sukor, Nor Azmi Kamaruddin · 2018 · Intern J Endocrinol Metab
67. Hypertension in Cushing’s Syndrome
    Filippo Ceccato, Mattia Barbot, Carla Maria Scaroni, Marco Boscaro · 2020 · Updates in hypertension and cardiovascular protection
68. DIFFERENT SURGICAL OPTIONS IN CUSHING’S DISEASE
    Ana Valea, Cristina Ghervan, Mara Carşote, Simona Elena Albu, Carmen Emanuela Georgescu · 2016 · Journal of Surgical Sciences
69. Treatment of Primary Pigmented Nodular Adrenocortical Disease
    Xiaokun Gang, Guixia Wang, Xinming Liu, Siwen Zhang, Yunran Guo · 2022 · Hormone and Metabolic Research
70. Medical Treatment of Cushing’s Disease
    S. Hopkins, Maria Fleseriu · 2017 · Elsevier eBooks
71. Persistent Cushing’s Disease after Transsphenoidal Surgery: Challenges and Solutions
    Adriana Albani, Marily Theodoropoulou · 2020 · Experimental and Clinical Endocrinology & Diabetes
72. A Prospective Trial With Ketoconazole Induction Therapy and Octreotide Maintenance Treatment for Cushing's Disease
    Ticiana Paes, Rob van der Pas, Peter M. van Koetsveld, Fadime Dogan, Kees K A van den Berge, Romana Teodora Netea-Maier, Peter H L T Bisschop, Leo J. Hofland, Richard Abraham Feelders · 2025 · Journal of the Endocrine Society
73. “The Adrenal Gland: Central Relay in Health and Disease - Current Challenges and Perspectives 2018” – Cushing’s Disease
    G. K. Stalla, Denis Ciato, C. Dimopoulou · 2018 · Experimental and clinical endocrinology & diabetes
74. Caution Advised Using Combination Ketoconazole and PD-1 Inhibitors
    Yingying Yang, Joel Randolph Hecht, Sandy Ting Liu, Melissa J. Cohen, Steven D. Hart, Hanlin L. Wang, Anthony P. Heaney · 2020 · AACE Clinical Case Reports
75. Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole
    Christina Tatsi, Andréa Gutierrez Maria, Cole Malloy, Lin Lin, Edra London, Nick Settas, Chelsi L Flippo, Meg F. Keil, Fady Hannah‐Shmouni, Dax A. Hoffman et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
76. Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
    Takako Araki, Ning‐Ai Liu · 2018 · Frontiers in Endocrinology
77. Treatment of Cushing’s Syndrome : What Place for Medical Treatment?
    Olivier Chabre · 2019 · Acta Endocrinologica (Bucharest)
78. Ectopic Corticotropin-Releasing Hormone/Adrenocorticotropic Hormone-Co-Secreting Neuroendocrine Tumors Leading to Cushing’s Disease: A Case Presentation and Literature Review
    Jasmin Ewert, Maximilian Seidl, Jann Achim Hommen, Matthias Schott, Norbert Gattermann · 2025 · Neuroendocrinology
79. Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing’s Disease in Spain
    Marta Araujo Castro, Rogelio García-Centeno, Laura González Fernández, Felicia Alexandra Hanzu, Aida Orois, Rosa Cámara, María Dolores Ollero García, Ana Irigaray, Paola Gracia Gimeno, Eider Pascual Corrales et al. · 2025 · Journal of Clinical Medicine
80. Discontinuation of Drug Treatment in Cushing's Disease Not Cured by Pituitary Surgery
    Adel Ghalawinji, Lucas Drezet, Philippe C. Chaffanjon, Marie Muller, Nathalie Stürm, Anna Simiand, Arnaud Lazard, Emmanuel Gay, Olivier Chabre, Justine Cristante · 2023 · The Journal of Clinical Endocrinology & Metabolism
81. Efficacy and Safety of Levoketoconazole in Managing Cushing’s Syndrome: A Systematic Review
    Shinjan Patra, Deep Dutta, Lakshmi Nagendra, Nishant Raizada · 2024 · Indian Journal of Endocrinology and Metabolism
82. LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing’s Syndrome
    David Balakirouchenane, Axelle Vasseur, Fidéline Bonnet-Serrano, Minna Choi, Nihel Khoudour, Alicja Puszkiel, Lionel Groussin, Michel Vidal, Xavier Declèves, Jerome Yves Bertherat et al. · 2023 · Journal of Pharmaceutical and Biomedical Analysis
83. Cushing’s Syndrome: A Historic Review of the Treatment Strategies and Corresponding Outcomes in a Single Tertiary Center over the Past Half-Century
    Anelia Nankova, Maria Yaneva, Atanaska P. Elenkova, Dimitar Tcharaktchiev, Marin Marinov, Asen Hadzhiyanev, Tanyo Sechanov, Georgi Gantchev, Georgi Todorov, Georgi Кirilov et al. · 2018 · Hormone and Metabolic Research
84. Efficacy and safety of pasireotide for Cushing's disease
    Nairui Zhao, Xinxin Yang, Cuiliu Li, Jie Ma, Xiuping Yin · 2020 · Medicine
85. Osilodrostat‐induced adrenal insufficiency in a patient with Cushing's disease
    Catherine Ekladios, Jessica Khoury, Shahzad Mehr, Krystel Feghali · 2022 · Clinical Case Reports
86. Adrenocortical carcinoma, an unusual cause of secondary hypertension
    Daniel Veron Esquivel, Fernando Batiz, Alfonso Farias Vega, Perla A. Carrillo Gonzalez · 2016 · BMJ Case Reports
87. Fluconazole treatment in severe ectopic Cushing syndrome
    Teresa Mabel Canteros, Valeria de Miguel, Patricia Day · 2019 · Endocrinology Diabetes and Metabolism Case Reports
88. Melatonin ameliorates ketoconazole-induced increase in thyroid function
    Abdullateef Isiaka Alagbonsi, Luqman Aribidesi Olayaki, Halimat Amin Abdulrahim, Mariam Titilayo Suleiman, Israel Bojuwade, Noah Adavize Omeiza, Sheu Oluwadare Sulaiman · 2020 · Rwanda Journal of Medicine and Health Sciences
89. Cushing's Syndrome in the Elderly
    Aleksandra Zdrojowy-Wełna, Elena Valassi · 2024 · Experimental and Clinical Endocrinology & Diabetes
90. Medical Treatment of Cushing’s Syndrome
    Laurence Guignat, Jerome Yves Bertherat · 2025 · Endocrinology and Metabolism
91. A preliminary model to tailor osilodrostat in patients with Adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome
    Cécilia Piazzola, Frédéric Castinetti, Katharina von Fabeck, Nicolas Simon · 2025 · European Journal of Endocrinology
92. Cushing’s disease: role of preoperative and primary medical therapy
    Frédéric Castinetti · 2022 · Pituitary
93. Effects of Ketoconazole on the Pharmacokinetics of Mifepristone, a Competitive Glucocorticoid Receptor Antagonist, in Healthy Men
    Dat Nguyen, Sarah Mizne · 2017 · Advances in Therapy
94. Advances in the Diagnosis and Medical Management of Cushing's Syndrome
    Danae Anastasia Delivanis, Anu Rani Sharma, Oksana Hamidi, Meera Shah, Irina Bancos · 2019 · Elsevier eBooks
95. Past, Present, and Future of Therapies for Pituitary Neuroendocrine Tumors: Need for Omics and Drug Repositioning Guidance
    B. Aydin, E. Yıldırım, Onur Erdogan, K. Arğa, B. Yilmaz, S. Bozkurt, F. Bayraklı, B. Turanli · 2022 · Omics
96. Assessment of the outcomes of the treatment of Cushing's disease in the hospitals of Castilla-La Mancha
    Isabel Huguet, Miguel Aguirre, Almudena Vicente, Mubarak Alramadán, Iván Quiroga, Júlia Silva, Cristina Lamas · 2015 · Endocrinología y Nutrición (English Edition)
97. Análisis de los resultados del tratamiento de la enfermedad de Cushing en los hospitales de Castilla-La Mancha
    Isabel Huguet, Miguel Aguirre, Almudena Vicente, Mubarak Alramadán, Iván Quiroga, Júlia Silva, Cristina Lamas · 2015 · Endocrinología y Nutrición
98. Cushing Disease: Diagnosis and Treatment
    Christina Tatsi, Constantine A. Stratakis · 2019 · Contemporary Endocrinology
99. High Prevalence of Adrenal Remnant Tissue in Patients Undergoing Bilateral Adrenalectomy for Cushing’s Disease
    Julian Bryant Wilson, Mohan Zopey, Jaimie M Augustine, Randolph L. Schaffer, Manfred Chiang, Theodore C. Friedman · 2020 · Hormone and Metabolic Research
100. Rapid and long-lasting response to selpercatinib of paraneoplastic Cushing’s syndrome in medullary thyroid carcinoma
     Marine Sitbon, Porhuoy Chou, Seydou Bengaly, Brigitte Poirot, Marie Laloi-Michelin, Laure Deville, Atanas Pachev, Ahouefa Kowo-Bille, Clément Dumont, C. Chougnet · 2022 · European Thyroid Journal